Floatz logo

Cytokine Induced Memory-Like Natural Killer Cells

Chromophobe Renal Cell Carcinoma

Dana-Farber Cancer InstituteCell therapyEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Chromophobe Renal Cell Carcinoma cohort.

Asset / SponsorPhaseRating
Bms-907351
Bradley A. McGregor, MD
Phase 2B
gw786034
Mayo Clinic
Phase 2B
Nivolumab
Bradley A. McGregor, MD
Phase 2CCC
Ipilimumab
Bradley A. McGregor, MD
Phase 2CCC
Sorafenib
National Cancer Institute (NCI)
Phase 1/2CCC

View all 11 →

Same molecule, other indications

Cytokine Induced Memory-Like Natural Killer Cells is also rated in:

Myeloproliferative DisordersDormant
CC
Indicative ·
43 / 100
View asset →
myeloid leukemiaDormant
CC
Indicative ·
41 / 100
View asset →
myeloproliferative neoplasmDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →